Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of the combination of chromium picolinate (600 μg Cr) + biotin (2 mg)
versus placebo on glycosylated hemoglobin (HbA1c), lipid profiles (Total-C, HDL-C, LDL-C,
TGs, TG/HDL ratio, etc), and pharmacoeconomic outcomes as measured at the Baseline Visit and
90 days later at the Final Visit. Secondarily, to measure the effect of chromium picolinate
(600 μg Cr) + biotin (2 mg) versus placebo on patient quality of life, fasting and
post-prandial blood sugar levels, fasting insulin, and anti-hyperglycemic medication usage.